Neochem Bio Solutions Ltd (NEOCHEM) is currently trading at 108.40 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Neochem Bio Solutions Limited manufactures specialty performance chemicals across polymers, surfactants, silicones and bio-based esters, supplying textiles, home & personal care, institutional cleaners, water treatment, paints, paper, construction and rubber markets from a 22,000 MTPA integrated facility in Moraiya, Ahmedabad with in-house R&D and QA/QC labs. The business delivered rapid financial scale in FY26, reporting revenue of ₹110.7 crore and PAT of ₹12.0 crore, driven by 32% revenue growth and an expansion in EBITDA margin to 20.4%, demonstrating early-stage operating leverage in a traditionally fragmented specialty chemicals market. Neochem is consciously pivoting toward sustainable chemistries: it holds GOTS 7.0 and ZDHC Level 3 certifications, commercializes vegan ester quats and bio-based surfactants, and has exclusive distribution rights for fluorine-free repellents, positioning the company to capture regulatory-driven premium demand for eco-friendly formulations. Despite improving profitability metrics and a strengthened balance sheet after listing, the company shows working capital stress with debtor days rising to 122 and cash from operations sharply negative in FY26, highlighting near-term liquidity and receivables management as key operational priorities.

Over the past 52 weeks, Neochem Bio Solutions Ltd has traded between a low of ₹63.00 and a high of ₹121.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Neochem Bio Solutions Ltd has a market capitalization of approximately 185.59. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Neochem Bio Solutions Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 24.14 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 185.59 Cr, Neochem Bio Solutions Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Neochem Bio Solutions Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Neochem Bio Solutions Ltd is 24.14. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The board considered and approved the unaudited financial results for the half year ended September 30, 2026 at its meeting on October 27, 2026.